Indianapolis, IN4 days ago
The ideal candidate will have an independent or emerging laboratory program focused on GU cancer biology, drug development, biomarkers, therapeutic resistance, tumor microenvironment, immuno-oncology, radiopharmaceuticals, antibody-drug conjugates, targeted therapies, or other translational areas relevant to GU cancers. The candidate will join an established GU oncology program with a robust clinical trials portfolio and contribute to discoveries that drive novel therapies, biomarker development, correlative science, and investigator-initiated clinical trials.